Pfizer To Expand Pearl River Campus

PEARL RIVER, NY — Pfizer announced plans for a $470 million transformational investment for its Vaccine Research and Development campus in Pearl River.

According to a spokesperson, over the next three years, subject to approvals from officials and other entities as required, the company plans to expand and modernize the Pearl River campus.

The plans include a new 260,000-square-foot lab building for 370 employees.

There will also be amenities such as a modern cafe, fitness center, parking garage and functional outdoor plaza.

A prominent main entrance will be added, and buildings will be connected in the modernization.

The Pearl River facility has been the hub of the company's vaccine research, including Pfizer's partnership with BioNTech SE, Bloomberg reported.

With BioNTech, Pfizer developed the MRNA technology behind the COVID-19 vaccine.

Steve Bjornson, vice president and COO of vaccine research and development at Pfizer, said the company was running out of space.

"We're trying to keep up with the portfolio and enable the expansion of mRNA capacity," he told Bloomberg.